公司資料
PerkinElmer 股價、新聞與催化劑
- 股票代碼:
- RVTY
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
149.06 USD (-2.51%)
收盤價
最後更新: 2026年10月1日
11.2B USD
市值
股價為何變動
截至 2026年10月1日，RVTY 下跌 2.51%，收於 $149.06。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Health Science Tools and Diagnostics Company
Revvity provides technologies and services that support workflows from biological discovery through development and clinical diagnosis. Its customer base includes pharmaceutical and biotechnology companies, diagnostic laboratories, academic institutions, and government organizations.
Life Sciences Research Tools
The company offers imaging, detection, screening, automation, reagents, and assay technologies used in drug discovery and translational research. These tools help researchers study cells, proteins, genes, and disease mechanisms at multiple scales.
Translational Multi-Omics
Revvity's multi-omics capabilities combine genomic, transcriptomic, proteomic, and cellular analysis. The portfolio supports biomarker identification, target validation, and patient stratification across research and therapeutic-development workflows.
Diagnostics Portfolio
The diagnostics business supplies technologies for reproductive health, newborn screening, infectious disease, autoimmune testing, and other clinical applications. Instruments, assays, and laboratory software create recurring demand from regulated testing workflows.
Informatics and Workflow Integration
Revvity integrates laboratory informatics, data management, and analytics with its instruments and assays. This approach is intended to connect experimental data, automate interpretation, and improve continuity from discovery research to clinical use.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。